Search

everythinglearnresearchcommunity

for

Search:↓

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Minoxidil can cause deadly skin reaction; monitor patients closely.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Hirsutism causes significant psychological distress in women.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Different growth patterns in thyroid tumors are influenced by where cell growth and death occur.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.